Literature DB >> 2432195

Remyelination by oligodendrocytes stimulated by antiserum to spinal cord.

M Rodriguez, V A Lennon, E N Benveniste, J E Merrill.   

Abstract

The new synthesis of myelin and the proliferation of oligodendrocytes was stimulated by serum from syngeneic mice immunized with homogenized spinal cord (SCH). Treatment with this antiserum produced a 10-fold increase in the area of remyelination in spinal cords that had become demyelinated previously as a result of infection by Theiler's murine encephalomyelitis virus. Inflammation was decreased in regions of white matter that showed remyelination. Oligodendrocytes exposed to anti-SCH in vitro incorporated three to five times more [3H]thymidine than resting cells did and expressed more myelin basic protein in their cytoplasm, suggesting stimulation of myelinogenesis. Thus, there is a factor present in anti-SCH antiserum that stimulates central nervous system-type remyelination. This finding may provide clues for the therapy of patients with demyelinating disorders such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432195     DOI: 10.1097/00005072-198701000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  27 in total

Review 1.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

Review 2.  Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation.

Authors:  R Schwartz-Albiez; R C Monteiro; M Rodriguez; C J Binder; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 3.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

Review 4.  The neuroprotective role of inflammation in nervous system injuries.

Authors:  Jorge Correale; Andrés Villa
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

5.  Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis.

Authors:  Xiaohua Xu; Aleksandar Denic; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  J Clin Immunol       Date:  2012-09-19       Impact factor: 8.317

6.  Method of identifying natural antibodies for remyelination.

Authors:  Arthur E Warrington; Moses Rodriguez
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 7.  Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.

Authors:  Lisa K Peterson; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2006-12-28       Impact factor: 3.478

Review 8.  Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.

Authors:  Jens O Watzlawik; Bharath Wootla; Meghan M Painter; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2013-09       Impact factor: 4.618

9.  Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Authors:  J H Noseworthy; P C O'Brien; B G van Engelen; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 10.  Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

Authors:  B G van Engelen; D J Miller; K D Pavelko; O R Hommes; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.